DataVXSmallPaper
journal article·2025-03Open access

Harnessing Lactobacillus reuteri ‐Derived Extracellular Vesicles for Multifaceted Cancer Treatment (Small 10/2025)

Soyeon Yi, Eunkyeong Jung, Hyeran Kim, Jinsol Choi, Suhyeon Kim, Eun‐Kyung Lim, Kwang‐Sun Kim, Taejoon Kang, Juyeon Jung

Small· Volume 21· Issue 10
Publisher pageOpen full text
Source abstract

Abstract

Cancer Treatments Extracellular vesicles derived from the probiotic Lactobacillus reuteri (REVs) exhibit remarkable antitumor efficacy through oral administration, leveraging their stability in the gastrointestinal environment and inherent therapeutic effects. When combined with photothermal therapy, REVs encapsulating photosensitizers effectively target and eradicate lung tumors, highlighting their potential as a versatile platform for standalone or combinational cancer treatments. More in article number 2406094, Taejoon Kang, Juyeon Jung, and co-workers.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Bionanotechnology Research Center Korea Research Institute of Bioscience and Biotechnology (KRIBB) 125 Gwahak‐ro, Yuseong‐gu Daejeon 34141 Republic of Korea

College of Pharmacy Korea University Sejong 30019 Republic of Korea

Department of Fundamental Pharmaceutical Sciences Graduate School Kyung Hee University 26 Kyungheedae‐Ro, Dongdaemun‐Gu Seoul 02447 Republic of Korea

Department of Nanobiotechnology KRIBB School of Biotechnology UST 217 Gajeong‐ro, Yuseong‐gu Daejeon 34113 Republic of Korea

School of Pharmacy Sungkyunkwan University 2066 Seobu‐ro, Jangan‐gu Suwon 16419 Republic of Korea

Department of Chemistry and Chemistry Institute for Functional Materials Pusan National University 2 Busandaehak‐ro, Geumjeon‐gu Busan 46241 Republic of Korea

References

Reference metadata was not supplied for this record.